KDR and neoplasm: It effectively inhibits the phosphorylation of VEGFR on vascular endothelial cell surfaces and downstream signal transduction, thereby inhibiting the proliferation, migration, and tube formation of vascular endothelial cells, blocking the formation of new tumour blood vessels, and thus inhibiting tumour growth [10].